Výsledky vyhledávání - "May, Montellano"

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine

Autor: Myew-Ling Toh, Celine Zocchetti, Jaime Santos, Rontgene Solante, Stephanie Meyer, Cesar Mascareñas, Nicole Perreras, Claire Vigne, May Montellano

Publikováno v: Pediatric Infectious Disease Journal. 40:856-863

Background Incorporating dengue vaccination into existing childhood vaccination programs could increase vaccine coverage. This study assessed the safety and immunogenicity of concomitant versus sequential administration of the combined tetanus toxoid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::24b943a615889197434cf833154bd3d5
https://doi.org/10.1097/inf.0000000000003220

Zobrazit plný text záznamu

Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial

Publikováno v: The Pediatric Infectious Disease Journal

Supplemental Digital Content is available in the text.
Background: We evaluated an inactivated quadrivalent influenza vaccine (IIV4) in children 6–35 months of age in a phase III, observer-blind trial. Methods: The aim of this analysis was to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d8ab0201f8729a837b43fd82126b21
https://pubmed.ncbi.nlm.nih.gov/31725115

Zobrazit plný text záznamu

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age

Autor: Charissa Fay Corazon B. Tabora, Birgit Thierry-Carstensen, Lulu Bravo, Josefina Carlos, Mie Vestergaard Kusk, Ananda S Bandyopadhyay, Salvacion R. Gatchalian, Charlotte Sørensen, Pernille Ingemann Nielsen, May Montellano, Henrik Wachmann, Pernille N. Tingskov

Publikováno v: Vaccine

Background A dose-sparing inactivated polio vaccine (IPV-Al), obtained by adsorption of inactivated virus to an aluminium hydroxide adjuvant, can help mitigate global supply and the cost constraints of IPV. The objective of this trial was to demonstr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692db1b072cbbba0675865bc755729a4
https://pubmed.ncbi.nlm.nih.gov/31703934

Zobrazit plný text záznamu

Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons

Autor: Carine Claeys, Khalequ Zaman, Ghassan Dbaibo, Ping Li, Allen Izu, Pope Kosalaraksa, Luis Rivera, Beatriz Acosta, Maria Luisa Arroba Basanta, Asma Aziz, Miguel Angel Cabanero, Vijayalakshmi Chandrashekaran, Bartholomew Corsaro, Luis Cousin, Adolfo Diaz, Javier Diez-Domingo, Ener Cagri Dinleyici, Saul N Faust, Damien Friel, Jose Garcia-Sicilia, Grace D Gomez-Go, Maria Liza Antoinette Gonzales, Stephen M Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Ludovic Malvaux, Josep Mares Bermudez, Federico Martinon-Torres, Mariano Miranda, May Montellano, Maria Amor Peix Sambola, Roman Prymula, Thanyawee Puthanakit, Renata Ruzkova, Iwona Sadowska-Krawczenko, Ignacio Salamanca de la Cueva, Etienne Sokal, Jyoti Soni, Henryk Szymanski, Angels Ulied, Anne Schuind, Varsha K Jain, Bruce L Innis, Beatriz Acostas, Arshad Amanullah, Miguel Ariza, Milagros Bautista, Ashish Bavdekar, Bhavesh Bodalia, Lulu C Bravo, Jerzy Brzostek, Ian Caldwell, Alfonso Carmona, Jasur Danier, Ana Isabel Diaz Cirujano, Martine Docx, Daniel Drazan, Andrzej Galaj, Fermin Garcia Rodriguez, Trevor Gooding, Mustafa Hacimustafaoglu, Paul Heath, Paul Heaton, Sanjay Lalwani, Jennifer Langlands, Karl Logghe, Jolanta Mantyka, Damien McNally, Edyta Miszczak-Kowalska, Simon Royal, Benjamin Sablan, Matthew Snape, Richard Tomlinson, Marc Verghote, Andre Vertruyen, Marie Wheeler

Publikováno v: LANCET CHILD & ADOLESCENT HEALTH
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

BackgroundDespite the importance of vaccinating children younger than 5 years, few studies evaluating vaccine prevention of influenza have been reported in this age group. We evaluated efficacy of an inactivated quadrivalent influenza vaccine (IIV4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2b340ce6383216acb8bc04f9d8ea904
https://pubmed.ncbi.nlm.nih.gov/30169261

Zobrazit plný text záznamu

Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial

Publikováno v: Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
The Journal of Infectious Diseases

GlaxoSmithKline Biologicals Background. the vaccine efficacy (VE) of 1 or 2 doses of AS03-adjuvanted influenza A(H1N1) vaccine relative to that of 2 doses of nonadjuvanted influenza A(H1N1) vaccine in children 6 months to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d631b1be0a1ed5db8e948a4cb23910a
https://doi.org/10.1093/infdis/jiu173

Zobrazit plný text záznamu

Routine Newborn Hepatitis B Immunization

Autor: Usa Thisyakorn, Andrew Lane, May Montellano

Publikováno v: Infectious Diseases in Clinical Practice. 19:326-331

This article reviews the arguments for a hepatitis B vaccination schedule at birth and at 1 month and 6 months of age. Vertical transmission is a major route of hepatitis B infection and in 2009 the World Health Organization stated that "All infants

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::987bfc502caecfedc1d4fdab3bfc2bfc
https://doi.org/10.1097/ipc.0b013e31822b7dda

Zobrazit plný text záznamu

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

Autor: Wolfgang Jilg, Veerachai Watanveerade, Tino F. Schwarz, Ping Li, May Montellano, Gérard Zalcman, Serge Fitoussi, David W. Vaughn, Angkool Kerdpanich, Odile Launay, Xavier Duval, Vinod Bambure, Paul Gillard, Adrian Caplanusi, Anuradha Madan, Jürgen J. Wenzel

Publikováno v: BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2013, 13 (1), pp.435. ⟨10.1186/1471-2334-13-435⟩

Pandemic influenza vaccine manufacturing capacity and distribution agility is enhanced through the availability of equivalent antigen-sparing vaccines. We evaluated equivalence in terms of immunogenicity between GlaxoSmithKline Vaccines’ A/Californ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8267ecf34b2938ffe505d0a3ad5bf45e
https://www.hal.inserm.fr/inserm-00868824

Zobrazit plný text záznamu

Immunogenicity of a single dose of tetravalent meningococcal serogroups A, C, W-135, and Y conjugate vaccine administered to 2- to 10-year-olds is noninferior to a licensed-ACWY polysaccharide vaccine with an acceptable safety profile

Autor: Valsan Philip Verghese, Anand Prakash Dubey, Marie Van der Wielen, Veronique Bianco, Salvacion Gatchalian, Ghassan Dbaibo, Hemant Jain, Jacqueline M. Miller, Ziad A. Memish, May Montellano

Publikováno v: The Pediatric infectious disease journal. 30(4)

Meningococcal disease remains an important cause of invasive bacterial infections in children less than 5 years of age. Immunogenicity and safety of the investigational ACWY vaccine conjugated with tetanus toxoid (ACWY-TT, GlaxoSmithKline Biologicals

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b834d9dde62bb519a259ccd0fe31edb3
https://pubmed.ncbi.nlm.nih.gov/21278617

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání